This document provides information on microbiology and parasitology. It discusses microorganisms like bacteria, parasites, fungi and viruses. It also describes different types of parasites including protozoa and helminths. Specifically, it summarizes the life cycle, symptoms, diagnosis and treatment of Entamoeba histolytica, which causes amoebiasis. It notes that amoebiasis is common in developing countries where sanitation is poor and transmission occurs through the fecal-oral route by ingesting cysts from contaminated food or water. Stool examination is used to diagnose by identifying trophozoites or cysts of E. histolytica.
Visceral leishmaniasis (VL), also known as kala-azar, is the most severe form of leishmaniasis caused by the protozoan parasite Leishmania donovani and transmitted by the infected sandflies. It characterized by irregular bouts of fever, substantial weight loss, swelling of the spleen and liver, and anaemia.
Visceral leishmaniasis (VL), also known as kala-azar, is the most severe form of leishmaniasis caused by the protozoan parasite Leishmania donovani and transmitted by the infected sandflies. It characterized by irregular bouts of fever, substantial weight loss, swelling of the spleen and liver, and anaemia.
An introduction to Medical Parasitologyrinki singh
Medical parasitology: “the study and medical implications of parasites that infect humans”. A parasite: “a living organism that acquires some of its basic ...
Classification of medical parasitology Lec.2.pptxnedalalazzwy
Parasitology is the scientific discipline concerned with the study of the biology of parasites and parasitic diseases, including the distribution, biochemistry, physiology, molecular biology, ecology, evolution and clinical aspects of parasites, including the host response to these agents.
Strategies Novartis can use to GROW from a Billion Dollar Company to a Trillion Dollar Company like Alphabet Inc
Novartis is a leading healthcare company which is situated in Switzerland and uses digital technologies and innovative science to come up with transformative ways of treatment in areas of great medicinal needs. This article explains what Novartis strategies and what they should employ so that they can rise from a billion dollar company to a trillion dollar company like the Google Alphabet Inc.
Novartis was formed in March 1996 by the merging of pharmaceutical and agrochemical divisions of Ciba-Geigy and Sandoz companies. Thanks to the merging of the two companies, Novartis is one of the biggest pharmaceutical companies in the world. Novartis is one of the largest companies which achieved a great milestone within a few decades. Novartis as a whole is divided into three major divisions: Sandoz (generics), Innovative Medicines and Alcon (eyecare). Novartis is also involved in collaborative research projects that are publicly funded.
Below are some of Novartis best selling drugs and their revenue
1.Cosenty – This is the top selling drug with a revenue of 4.788 billion dollars
2.Enfresto – This has a revenue of 4.644 billions dollars
3.Promacta – This has a revenue 0f 2.088 billion dollars
Medicine manufactured by Novartis and their uses
Medicine Medicine use
Cosentyx Used to treat psoriatic arthritis
Entresto Used to treat heart failure
Lucentis Used to block abnormal vessel growth in the back of the eye
Tasigna Used to treat chronic myelogenous leukemia which has the Philadelphia chromosome
Jakavi Used to treat myelofibrosis, polycythemia vera and graft-versus-host disease
Promacta Used to treat patients with abnormal low platelet count
Sandostatin Used to treat patients with tumor experiencing symptoms like flushing and diarrhea
Xolair Used to treat moderate and severe asthma
Gilenya Used to treat multiple sclerosis
How Novartis became one of the biggest pharmaceutical companies in the world
1.Market control through partnership
Geigy, Sandoz and Ciba combined their power so that they can compete with strong foreign firms and formed a cartel called the Basal Syndicate or Basal IG. Basal IG secured most of the manufacturing facilities all over the US and across Europe. It later joined with IG Farben and other chemical companies to form a big cartel called the Quadrapartite Cartel which dominated all of the European market and enjoyed the profits made from the joint manufacturing.
2.Growth acceleration through mergers
Since competition was very rampant in the pharmaceutical industry, Ciba and Geigy decided to merge with Sandoz AG to form Novartis. With this merge, Novartis became one of the growing giants in the pharmaceutical industry. This made Novartis gain a lot of fame and build a strong reputation over other companies. Novartis majored on agrochemical and pharmaceutical industries which made it easy to focus on a specific mar
8. • A. PROTOZOA (Unicellular organism)
4 types according types of organs for locomotion
Amoebae - pseudopodia;
Flagellates - flagella;
Ciliates - cilia and
Sporozoa – absence of locomototion
B. METOZOA ( Multicellular organism )
9. A. PROTOZOA (Unicellular organism)
AMOEBA SPOROZOA FLAGELLETS
Plasmodium
Entamoeba Histolytica 1. Leishmenia
Plasmodium vivax
(Eat tissue) L .Donovani
Plasmodium ovale L. Tropica
L. Mexicana
Plasmodium malariae
L. Brasiliensis
Plasmodium falciparum
2. Intest: Flagellets
Giardia Lamblia
3. Ciliate:
Balantadium coli
12. STAGES IN LIFE CYCLE OF PROTOZOA
Infective stage: –
Cysts, Oocysts, Sporozoites, Spores-
dormant stages and Resistant
Vegetative stage: –
Trophozoites – take nourishment
from the hosts; invasive causing pathology;
most are motile.
13. LUMINAL PROTOZOA
- COLONIZE THE LUMINAL ORGANS-
intestinal tract and the urogenital tract
- TWO STAGES – I ) Trophozoite (vegetatative / invasive)
II) Cyst (infective)
15. Life cycle:
inhabit the large intestine; the cyst is the
infective stage. On ingestion – excyst into
amoebulae –
trophozoites which is the vegitative stage –
invade the mucosa to absorb nourishment
from tissues dissolved by its cytolytic enzymes
and also ingest RBCs.
16. Helminthes Eggs / Ova
• Ancylostoma duodenale
Hymenolopis Nana
• Ascaris lumbricoids Trichus Trichuria
• Enterobius Vermiculus
• T. saginata
• T. solium
• Cysticercosis
• E. Granulosus
•
Diphylobothrium latum
21. The Organism
4 species of Entamoeba:
Nonpathogenic: Pathogenic:
- E. dispar, -
E.histolytica
– E. coli,
– E. hartmanni
22. Amoebiasis
Parasitic infection caused by the protozoan
Entamoeba histolytica
2nd to Malaria as protozoan cause of death
worldwide
1
23. Epidemiology
Helminthes, or parasitic worms, including
• Nematodes,
• Flukes and
• Tapeworms,
collectively infect approximately 2 billion people worldwide,
or about a third of the world population.
The majority of infected people reside in developing countries in
tropical & temperate climate zones,
where helminthes constitute a significant public health concern
24. Epidemiology
. Increased prevalence in developing countries (up to
25%)
• Principal frequency in countries with a deficiency
in sanitary conditions
• Poorest areasMost infected people.
• perhaps 90%, are asymptomatic, but this disease
has the potential to make the sufferer dangerously
ill.
25. Frequency
Region Infection Diasease Deaths
Africa 85 millions 10 millions 10-30
thousands
Asia 300 millions 20-30 25-50
millions thousands
Europe 20 millions 100 Minimum
thousands
America 95 millions 10 millions 10-30
thousands
Totals 650 millions 45-50 40-110
millions thousands
28. The Life Cycle
• 1. Cyst Stage
• Infective stage
• Survive from –4 to 40 Celsius
• Size – 12mm
• Quadrinucleated
• Ingested by contact with fecally
contaminated food
• Passes through stomach, excysts in
lower small bowel.
• Metacystic amoeba with four cystic
nuclei from each cyst
• 8 Small trophozoites from each
metacystic amoeba
• Trophozoites carried to cecum
29. LIFE CYCLE
Amebiasis is an
infection of the intestine, liver, or other tissues
by pathogenic amebas
(protozoan parasites).
E. histolytica is found primarily in
the colon where it can live as a
non-pathogenic commensal or
invade the intestinal mucosa
(green).
The ameba can metastasize to
other organs via a
hematogenous route (purple);
primarily involving the portal
vein and liver. The ameba can
also spread via a direct
expansion (blue) causing a
pulmonary infection, cutaneous
lesions or perianal ulcers
30.
31.
32. The Pathogenesis
• Area most commonly • Flask-shaped ulcers
involved = Cecum, then
Recto-sigmoid area
• May invade blood vessels
causing thrombosis,
infarction and
dissemination via portal
circulation to liver and
• extra-intestinal sites eg.
brain, pleura, pericardium
and genito-urinary system.
34. 4. Mode of Transmission
Ingestion of mature cyst through
contaminated food or water
TRANSMISSION:
Faecal ---- oral route
Contaminated water
Contaminated meals
Street vendors of meal
anal-oral contact
35. 5. SUSCEPTIBILITY
1. Age: Any age (Young Adults, rarely below the age of 5 Years.)
2. Sex : Both
3. Immunity: An attack of the dis: does not confer
immunity. (Relapses are common)
4. Env: Factors:
– Poor education
– Poverty and overcrowding
– Unsanitary conditions
– HIV infection 5
38. CLINICAL FEATURES
INTESTINAL AMOEBIASIS: AMOEBIC LIVER ABSCESS:
Mild Abdominal discomfort Onset- Insidious
Pain Pain & tenderness in Rt:
hypochondrium
Irregular bouts of diarrhoea (With
or without blood & mucus)
Fever may be present Fever High grade (with Nausea,
Anorexia & Vomiting
Abdomen tender
Liver slightly enlarged & tender Usually there is single abscess
In case of Rupture going to
In Fulminant colitis- All features Peritoneum, Pleural cavity &
are Sudden & severe pericardial cavity.
39.
40. METHODS OF DIAGNOSIS
• fresh or suitably preserved faecal specimens
• smears of aspirates or scrapings obtained by proctoscopy
• aspirates of abscesses or other tissue specimens
1. Exam: of Stool: (confirmed by trophozoites or cysts)
• Macroscopic: offensive, dark brown semi fluid, mixed
• with blood & mucus
• Microscopic Exam: ( Fresh sample, 3 types of mounts)
• (Trophozoites & cyst)
• 1. With Normal saline- motile Trophozoites
• 2. With Iodine + saline – Helps to distinguish from other parasites
• 3. With Methylene blue – only stain leukocytes.
41. 2. Exam: of Blood: moderate Leukocytosis
Serological Tests: (often Negative)
(when stool exam: -ve)
(IHA indirect haemagglutination &
EIA enzyme immunoassays Positive in extra-intestinal disease
such as liver abscesses)
3. X-ray, ultrasound and CT scans
(also useful in the identification of amoebic abscesses)
4. Liver Aspirate:
• Chocolate color, thick in consistency Trophozoites from material from
wall of abscess (after 4-5 days)
42. TREATMENT
(A) Luminal Amoebic ides:
Diloxanide Furoate
500 mg tid x 10 days
Idoquinol &
Paramomycin
(B) Tissue Amoebic ides:
Metronidazole
Tinidazole
Secnidazole
followed by diloxanide furoate
43. Prevention & Control
A. HEALTH EDUCATION:-
reduce fecal-oral transmission
B. SANITATION:-
Clean measures in & around the houses.
Sate disposal of human excreta.
Hand washing after defecation and before meals.
Use of sanitary latrines.
C. WATER SUPPLY:-
Safe water supply.
Protection of water from faecal contamination.
Water filtration or boiling (more effective than chlorination)
D. FOOD HYGIENE:-
Protection of food against faecal contamination.
Thorough washing of raw vegetables. (By full strength of vinegar)
Vaccination:
– None available currently
– Prototype subunit vaccines based on the Gal/Gal Nac - lectin under
study
44. The Complications
• Complications of Intestinal amoebiasis:
– Fulminant Amoebic Colitis with Perforation
• May have a mortality rate of up to 50%
• Children less than 2 yrs at increased risk of
perforation
– Massive Haemorrhage
– amoeboma
– amoebic Stricture
• Resulting from fibrosis of intestinal wall